goods bought in one Member State and resold in another. Importers may do this where the same product costs significantly more on the home market, to maximize profits. The practice promotes competition to the benefit of consumers.
... the communication on parallel imports of proprietary medicinal products for which marketing authorization has already been granted, dated 6 May 1982 ...
